Total Payments
$8,611
2024 Payments
$825.43
Companies
32
Transactions
483
Medicare Patients
4,533
Medicare Billing
$572,133
Payment Breakdown by Category
Food & Beverage$6,937 (80.6%)
Consulting$1,575 (18.3%)
Education$99.45 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,937 | 474 | 80.6% |
| Consulting Fee | $1,575 | 4 | 18.3% |
| Education | $99.45 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,580 | 190 | $0 (2024) |
| Olympus Corporation | $1,575 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $757.53 | 69 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $705.82 | 48 | $0 (2023) |
| PFIZER INC. | $640.91 | 36 | $0 (2024) |
| Celgene Corporation | $589.77 | 47 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $292.17 | 18 | $0 (2023) |
| UCB, Inc. | $195.16 | 6 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $175.91 | 2 | $0 (2018) |
| Daiichi Sankyo Inc. | $155.26 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $825.43 | 66 | ABBVIE INC. ($526.90) |
| 2023 | $1,786 | 74 | Olympus Corporation ($735.00) |
| 2022 | $2,122 | 90 | Olympus Corporation ($840.00) |
| 2021 | $1,031 | 74 | AbbVie Inc. ($275.49) |
| 2020 | $768.19 | 55 | AbbVie Inc. ($245.00) |
| 2019 | $1,331 | 92 | AbbVie, Inc. ($374.05) |
| 2018 | $544.33 | 29 | PFIZER INC. ($207.90) |
| 2017 | $203.30 | 3 | BOSTON SCIENTIFIC CORPORATION ($108.65) |
All Payment Transactions
483 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Olympus America Inc. | Single Use Electrosurgical Hemostatic Forceps (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Endotherapy | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Neuroscience | ||||||
| 09/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.14 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.80 | General |
| Category: Neuroscience | ||||||
| 08/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.14 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,243 | 6,576 | $787,366 | $171,976 |
| 2022 | 28 | 1,179 | 2,382 | $542,735 | $142,299 |
| 2021 | 26 | 1,042 | 2,372 | $493,171 | $140,660 |
| 2020 | 25 | 1,069 | 1,974 | $477,455 | $117,198 |
Total Patients
4,533
Total Services
13,304
Medicare Billing
$572,133
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 16 | 4,544 | $204,480 | $42,291 | 20.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 91 | 93 | $106,950 | $17,950 | 16.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 80 | 263 | $39,450 | $12,839 | 32.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 184 | 471 | $70,650 | $11,334 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 119 | $16,660 | $10,085 | 60.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 73 | 169 | $29,575 | $10,062 | 34.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 106 | 110 | $85,800 | $8,737 | 10.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 65 | $12,350 | $8,350 | 67.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 69 | 69 | $62,100 | $6,638 | 10.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 74 | $7,400 | $4,576 | 61.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 97 | $5,947 | $4,475 | 75.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 43 | $7,740 | $4,389 | 56.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $17,600 | $3,758 | 21.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 103 | $4,748 | $3,636 | 76.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $6,880 | $3,347 | 48.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $16,000 | $2,720 | 17.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $20,300 | $2,620 | 12.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $4,320 | $2,589 | 59.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 19 | 22 | $18,260 | $2,556 | 14.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $10,400 | $2,331 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $3,040 | $2,137 | 70.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 48 | 53 | $3,710 | $2,073 | 55.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 28 | 28 | $3,920 | $1,831 | 46.7% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $25,200 | $293.28 | 1.2% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 47 | 49 | $686.00 | $188.65 | 27.5% |
About Dr. Jacob Breaux, M.D
Dr. Jacob Breaux, M.D is a Gastroenterology healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1437416617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Breaux, M.D has received a total of $8,611 in payments from pharmaceutical and medical device companies, with $825.43 received in 2024. These payments were reported across 483 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,937).
As a Medicare-enrolled provider, Breaux has provided services to 4,533 Medicare beneficiaries, totaling 13,304 services with total Medicare billing of $572,133. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lafayette, LA
- Active Since 04/12/2012
- Last Updated 05/23/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437416617
Products in Payments
- XELJANZ (Drug) $624.03
- STELARA (Biological) $589.12
- ZEPOSIA (Drug) $579.30
- RINVOQ (Biological) $553.60
- HUMIRA (Biological) $475.30
- ENTYVIO (Biological) $440.40
- SKYRIZI (Biological) $380.11
- CREON (Drug) $379.22
- Humira (Biological) $320.98
- Cimzia (Drug) $195.16
- TRULANCE (Drug) $185.64
- RESOLUTION CLIP (Device) $175.91
- REMICADE (Biological) $168.41
- INJECTAFER (Drug) $155.26
- GI Genius (Device) $145.33
- LINZESS (Drug) $145.19
- Entyvio (Biological) $91.08
- DIFICID (Drug) $84.98
- Mavyret (Drug) $83.71
- VIBERZI (Drug) $71.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lafayette
Dr. Kerri Glassner, D.o, D.O
Gastroenterology — Payments: $75,707
Gastroenterology $75,707
Dr. Jacob Karr, Md, MD
Gastroenterology — Payments: $42,466
Gastroenterology $42,466
Mr. Jacque Noel, Md, MD
Gastroenterology — Payments: $11,841
Gastroenterology $11,841
Dr. Ramu Raju, Md, MD
Gastroenterology — Payments: $11,609
Gastroenterology $11,609
Dr. Stephen Abshire, Md, MD
Gastroenterology — Payments: $8,695
Gastroenterology $8,695
Erick Salvatierra, Md, MD
Gastroenterology — Payments: $4,439
Gastroenterology $4,439